FindMyKOL
Clinical trialNCT02911571Active, not recruitingInterventional

PRospective Multiple Myeloma Impact Study

SponsorSkylineDxEnrollment250Multiple Myeloma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This will be a prospective, case-only, study to measure the impact of MMprofiler on treatment intention decisions in Multiple Myeloma patients.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Lombardi Comprehensive Cancer Center

    Washington D.C., District of Columbia, United States

  • Winship Cancer Institute, Emory University

    Atlanta, Georgia, United States

  • Hackensack University Medical Center

    Hackensack, New Jersey, United States

  • New York Presbyterian Brooklyn Methodist Hospital

    Brooklyn, New York, United States

  • Columbia University Medical Center

    New York, New York, United States

  • Weill Cornell Medicine

    New York, New York, United States

  • Levine Cancer Institute

    Charlotte, North Carolina, United States

  • Wake Forest Baptist Medical Center,

    Winston-Salem, North Carolina, United States

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
27 Feb 2018
Primary completion
18 Apr 2022
Completion
1 Oct 2026
Last update posted
28 Apr 2026
Registered enrollment
250
Registry id
NCT02911571
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.